BelHealth Investment Partners, a healthcare-focused private equity firm, announced the acquisition of the business and assets of Geritrex Corp. (“Geritrex” or the “Company”). Founded in 1978 and headquartered in Mt. Vernon, New York, Geritrex is a manufacturer and distributor of primarily topical generic OTC products and pharmaceuticals to patients in institutional healthcare settings. Geritrex’s prominent list of customers includes: the Veterans Administration, Columbia Presbyterian Hospital, Albert Einstein Hospital, St. Jude Hospital, Mayo Clinic and Duke University Hospital. Nathan Kronforst, BelHealth Managing Director, stated, “Given BelHealth’s deep experience in generic OTC products and pharmaceuticals, we have actively pursued investments in this segment and are excited to partner with Geritrex and build upon the success that the Company has achieved over the past thirty years. Geritrex’s product mix and customer base of over 5,000 hospitals and nursing homes positions it perfectly to take advantage of the aging demographic trends. We look forward to growing Geritrex into a national platform in this fragmented and growing industry segment.”
Market Pulse transactions shown herein are provided as a matter of public record. These transactions have been compiled from press releases, corporate announcements and other public sources to provide an overview of acquisition and merger activities within the healthcare and life sciences sectors.